Email Alert | RSS

Journal of Peking University(Health Sciences) ›› 2019, Vol. 51 ›› Issue (4): 673-677. doi: 10.19723/j.issn.1671-167X.2019.04.013

Previous Articles     Next Articles

Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI

Jing-yun WU1,Yue MI2,Shui LIU1,Lin YAO2,Qi TANG2,Zhi-song HE2,Xiao-ying WANG1,△()   

  1. 1.Department of Radiology, Peking University First Hospital, Beijing 100034, China
    2.Department of Urology, Peking University First Hospital, Beijing 100034, China
  • Received:2019-04-16 Online:2019-08-18 Published:2019-09-03
  • Contact: Xiao-ying WANG E-mail:cjr.wangxiaoying@vip.163.com

RICH HTML

   

PDF (PC)

Abstract:

Objective: To evaluate the diagnostic performance of MRI for the assessment of inferior vena cava (IVC) wall invasion by IVC thrombus in patients with renal cell carcinoma (RCC).Methods: We retrospectively collected patients who underwent radical nephrectomy and thrombectomy for RCC between 2010 and 2018 at Peking University First Hospital. All the patients underwent imaging on a 1.5 Tesla or 3.0 Tesla MRI scanner. Fifty-six patients met the inclusion criteria. Preoperative imaging was reviewed by two radiologists blinded to details of the patient’s surgical procedure and histopathology. Two radiologists measured the maximum anterior-posterior diameter and coronal diameters of the IVC and renal vein, and the craniocaudal extent of tumor thrombus, and evaluated the MRI features of IVC thrombus, including occlusion of the IVC lumen,the margin of the tumor thrombus (smooth vs. irregular), contact of the IVC thrombus and IVC wall, and altered signal of the IVC wall. Univariable and multivariable associations of clinical and radiographic features with IVC wall invasion were evaluated by Logistic regression.Results: Of the 56 patients [male: 43, female: 13, mean age: (55.64±0.43) years], 17 (30.36%) were detected with IVC wall invasion, and most were clear cell carcinoma. Tumor thrombus with IVC wall invasion showed an increase in length of IVC thrombus [(7.91±3.59) cm vs. (5.94±3.57) cm, P=0.049], and more features of complete occlusion of the IVC lumen (P=0.002),irregular margin of the IVC thrombs (P=0.005), contact of the IVC thrombus and IVC wall (P=0.001), and altered signal of the low-intensity vessel wall (P<0.001), with a sensitivity of 94.12% and a specificity of 79.49%.Conclusion: The present study indicates that MRI could be a means of evaluating RCC with IVC wall invasion, and the combination of tumor thrombus length and subjective impression of IVC wall invasion achieved a high sensitivity and specificity for diagnosis.

Key words: Carcinoma, renal cell, Thrombus, Vena cava, inferior, Magnetic resonance imaging

CLC Number: 

  • R737.11

Table 1

Clinical characteristics of the study population (IVC wall invasion group vs. no IVC wall invasion group)"

Items Invasion (n=17) No invasion (n=39) Statistics P
Age/years, x?±s 57.410±10.038 54.870±12.612 0.535 0.593
Gender, n (%) 1.759 0.180
Male 15 (88.235) 28 (71.795)
Female 2 (11.765) 11 (28.205)
Pathology type, n (%) 8.758 0.271
Clear cell carcinoma 13 (76.471) 30 (76.923)
Papillary carcinoma 2 (11.765) 6 (15.385)
Chromophobe cell carcinoma 0 2 (5.128)
Clear cell carcinoma mixed with papillary carcinoma 0 1 (2.564)
Clear cell carcinoma mixed with chromophobe cell carcinoma 1 (5.882) 0
Collecting duct carcinoma 1 (5.882) 0
Thrombus level, n (%) 3.893 0.273
Ⅰ 1 (5.882) 6 (15.385)
Ⅱ 13 (76.471) 31 (79.487)
Ⅲ 2 (11.765) 2 (5.128)
Ⅳ 1 (5.882) 0

Table 2

MRI features of the study population (IVC wall invasion group vs. no IVC wall invasion group)"

Items Invasion (n=17) No invasion (n=39) Statistics P OR 95%CI
Contact of the IVC thrombus and IVC wall, n (%) 11.793 0.001 12.000 2.398-60.050
No contact 2 (11.765) 24 (61.538)
Contact 15 (88.235) 15 (38.462)
Occlusion of the IVC lumen, n (%) 9.636 0.002 9.706 1.949-48.335
Filling 15 (88.235) 17 (43.590)
No filling 2 (11.765) 22 (56.410)
Margin of the thrombus, n (%) 7.806 0.005 5.804 1.585-21.245
Smooth 4 (23.529) 25 (64.103)
Irregular 13 (76.471) 14 (35.897)
Altered signal of the IVC wall, n (%) 24.521 7.349×10-7 34.286 6.346-185.237
Altered 15 (88.235) 7 (17.949)
No altered 2 (11.765) 32 (82.051)
Length of IVC thrombus/cm 7.906±3.592 5.939±3.570 1.961 0.049
Maximal anterior-posterior diameter of renal vein/cm 1.877±0.549 1.744±0.520 0.957 0.339
Maximal superior-inferior diameter of renal vein/cm 1.953±0.532 1.926±0.559 -0.080 0.936
Maximal anterior-posterior diameter of IVC/cm 3.288±0.704 2.672±1.300 1.837 0.066
Maximal coronal diameter of IVC/cm 3.041±0.780 2.672±1.300 1.641 0.101

Figure 1

ROC curve based on the binary Logistic regression model"

[1] Motzer RJ, Jonasch E, Agarwal N , et al. Kidney cancer, version 2.2017: NCCN Clinical Practice Guidelines in oncology[J]. J Natl Compr Canc Netw, 2017,15(6):804-834.
[2] Ljungberg B, Bensalah K, Canfield S , et al. EAU guidelines on renal cell carcinoma: 2014 update[J]. Eur Urol, 2015,67(5):913-924.
[3] Hatcher PA, Anderson EE, Paulson DF , et al. Surgical management and prognosis of renal cell carcinoma invading the vena cava[J]. J Urol, 1991,145(1):20-23.
[4] Lawindy SM, Kurian T, Kim T , et al. Important surgical consi-derations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus[J]. BJU Int, 2012,110(7):926-939.
[5] Guo HF, Song Y, Na YQ , et al. Value of abdominal ultrasound scan, CT and MRI for diagnosing inferior vena cava tumour thrombus in renal cell carcinoma[J]. Chin Med J (Engl), 2009,122(19):2299-2302.
[6] Neves RJ, Zincke H . Surgical treatment of renal cancer with vena cava extension[J]. Br J Urol, 1987,59(5):390-395.
[7] Ciancio G, Livingstone AS, Soloway M . Surgical management of renal cell carcinoma with tumor thrombus in the renal and inferior vena cava: the University of Miami experience in using liver transplantation techniques[J]. Eur Urol, 2007,51(4):988-994.
[8] Kwon TW, Kim H, Moon KM , et al. Surgical treatment of inferior vena cava tumor thrombus in patients with renal cell carcinoma[J]. J Korean Med Sci, 2010,25(1):104-109.
[9] Hatakeyama S, Yoneyama T, Hamano I , et al. Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center[J]. BMC Urol, 2013(13):47.
[10] Chen X, Li S, Xu Z , et al. Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience[J]. World J Surg Oncol, 2015(13):14.
[11] Whitson JM, Reese AC, Meng MV . Population based analysis of survival in patients with renal cell carcinoma and venous tumor thrombus[J]. Urol Oncol, 2013,31(2):259-263.
[12] 中华医学会泌尿外科学分化中国肾癌联盟, 中国肾癌伴下腔静脉癌栓诊疗写作组. 肾癌伴静脉癌栓诊治专家共识[J]. 中华泌尿外科杂志, 2018,39(12):881-884.
[13] Psutka SP, Boorjian SA, Thompson RH , et al. Clinical and radiographic predictors of the need for inferior vena cava resection du-ring nephrectomy for patients with renal cell carcinoma and caval tumour thrombus[J]. BJU Int, 2015,116(3):388-396.
[14] Hallscheidt PJ, Fink C, Haferkamp A , et al. Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation[J]. J Comput Assist Tomogr, 2005,29(1):64-68.
[15] Gupta NP, Ansari MS, Khaitan A , et al. Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins[J]. Urol Int, 2004,72(2):129-134.
[16] Cuevas C, Raske M, Bush WH , et al. Imaging primary and se-condary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging[J]. Curr Probl Diagn Radiol, 2006,35(3):90-101.
[17] Lawrentschuk N, Gani J, Riordan R , et al. Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review[J]. BJU Int, 2005,96(3):291-295.
[18] Adams LC, Ralla B, Bender YY , et al. Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI[J]. Cancer imaging, 2018,18(1):17.
[19] Aslam Sohaib SA, Teh J , et al. Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging[J]. J Urol, 2002,167(3):1271-1275.
[20] Oto A, Herts BR, Remer EM , et al. Inferior vena cava tumor thrombus in renal cell carcinoma: staging by MR imaging and impact on surgical treatment[J]. AJR Am J Roentgenol, 1998,171(6):1619-1624.
[21] Laissy JP, Menegazzo D, Debray MP , et al. Renal carcinoma: diagnosis of venous invasion with Gd-enhanced MR venography[J]. Eur Radiol, 2000,10(7):1138-1143.
[22] Alayed A, Krishna Sk, Breau RH , et al. Diagnostic accuracy of MRI for detecting inferior vena cava wall invasion in renal cell carcinoma tumor thrombus using quantitative and subjective analysis[J]. AJR Am J Roentgenol, 2019,212(3):562-569.
[23] Myneni L, Hricak H, Carroll PR . Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances[J]. Br J Urol, 1991,68(6):571-578.
[1] Bo PENG, Fangfang LIU, Wei YANG, Ruiping XU, Lei CHEN, Baozhong LI, Xinjia WANG, Ji KE, Wenlei YANG, Yu HE, Zhen LIU, Bolin HOU, Liqun ZHANG, Miaoping LIN, Lixin ZHANG, Fan ZHANG, Fen CAI, Huawen XU, Mengfei LIU, Ying LIU, Yaqi PAN, Zhonghu HE, Yang KE. Perioperative hyperglycemia predicts poorer prognosis of esophageal squamous cell carcinoma patients treated with esophagectomy [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 567-574.
[2] Fan SHU, Liyuan GE, Hanzhang DENG, Haoming YIN, Junyong OU, Shaohui DENG, Yichang HAO, Min LU, Zhanyi ZHANG, Peichen DUAN, Shudong ZHANG. Molecular characteristics for poor prognosis related renal cell carcinoma with lymph metastases [J]. Journal of Peking University (Health Sciences), 2026, 58(3): 631-640.
[3] Hao FU, Luyan SHEN, Bingyang HUANG, Shaohua MA. Clinical strategies for perioperative management of esophageal squamous cell carcinoma in the immunotherapy era [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 266-271.
[4] Haoming YIN, Zijie WANG, Fan SHU, Zhanyi ZHANG, Hui LIANG, Shudong ZHANG. Expression and significance of the FABP6 long transcript in clear cell renal cell carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 393-398.
[5] Jialin LI, Liqiao CHEN, Jiatian TANG, Yan WU, Anqiang WANG. Conversion therapy for hepatoid adenocarcinoma of the stomach: A case report [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 399-404.
[6] Zichen PAN, Kai CHEN, Yukun HOU, Bohan YANG, Jixin ZHANG, Yongsu MA, Xiaodong TIAN, Yinmo YANG. Research progress in clinical pathology and molecular mechanisms of pancreatic adenosquamous carcinoma [J]. Journal of Peking University (Health Sciences), 2026, 58(2): 431-435.
[7] Xiaolin WANG, Luyao LI, Wen ZHANG, Hongyan WANG. Clinicopathological analysis of mesonephric-like adenocarcinoma in the corpusuteri: A report of 3 cases [J]. Journal of Peking University (Health Sciences), 2025, 57(6): 1208-1212.
[8] Weihua HOU, Shujie SONG, Zhongyue SHI, Lu LIU, Mulan JIN. Neuroendocrine carcinoma with significantly vacuolar nucleus at the esophagogastric junction: A case report [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 1005-1009.
[9] Shang XIE, Luming WANG, Xinyuan ZHANG, Qiushi FENG, Yangyang XIA, Ziwei DAI, Xiaofeng SHAN, Zhigang CAI. Construction and application of oral squamous cell carcinoma organoid bank [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 847-851.
[10] Shaohai TANG, Baoming YANG, Jiankun LI, Lili ZHAO, Yifan WANG, Shunxiang WANG. HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 884-894.
[11] Xiaoyong YANG, Fan ZHANG, Lulin MA, Cheng LIU. Clinical characteristics and influencing factors of extraglandular invasion of prostatic ductal adenocarcinoma [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 956-960.
[12] Shenmo LI, Dandan SU, Jiyu LIN, Haodong SONG, Lulin MA, Xiaofei HOU, Guoliang WANG, Hongxian ZHANG, Jianfei YE, Shudong ZHANG. Prognostic analysis of laparoscopic simultaneous radical cystectomy and nephroureterectomy [J]. Journal of Peking University (Health Sciences), 2025, 57(5): 961-966.
[13] Boda GUO, Min LU, Guoliang WANG, Hongxian ZHANG, Lei LIU, Xiaofei HOU, Lei ZHAO, Xiaojun TIAN, Shudong ZHANG. Clinicopathological and prognostic differences between clear cell and non-clear cell renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 644-649.
[14] Zhanyi ZHANG, Min LU, Yuehao SUN, Jinghan DONG, Xiaofei HOU, Chunlei XIAO, Guoliang WANG, Xiaojun TIAN, Lulin MA, Hongxian ZHANG, Shudong ZHANG. Clinicopathological features and survival analysis of TFE3-rearranged renal cell carcinoma with venous tumor thrombus [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 650-661.
[15] Zeyuan WANG, Shuanbao YU, Haoke ZHENG, Jin TAO, Yafeng FAN, Xuepei ZHANG. A preoperative prediction model for pelvic lymph node metastasis in prostate cancer: Integrating clinical characteristics and multiparametric MRI [J]. Journal of Peking University (Health Sciences), 2025, 57(4): 684-691.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Copyright © Journal of Peking University (Health Sciences), All Rights Reserved.
Powered by Beijing Magtech Co. Ltd